Genetic diagnosis and personalized medicine for epilepsy patients
Official title: Characterization of Patients With Epilepsy With an Integrated Approach of Clinical, Neurophysiological, Neuroradiological, Neuropsychological and Laboratory (Exome) Methods for Personalized Medicine
Run by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT06321822 · Data updated 2026-11-12
This study is testing if looking at the genes of people with epilepsy can help doctors find better, personalized treatments for them.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico Academic / other |
| Locations | 1 site (Milan) |
| Status | Recruiting |
| Started | August 2, 2021 |
| Main results expected | August 2, 2025 |
| Study ends | December 31, 2026 |
| Registry record updated | March 20, 2024 |
| Trial ID | NCT06321822 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include both minors and adults diagnosed with epilepsy who are being followed at the participating epilepsy clinics.
✕Probably not a fit
Patients with epilepsy who do not have available DNA samples from themselves and both parents may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to investigate the genetic causes of epilepsy by collecting clinical and instrumental data from patients at their first outpatient visit and one year later. It focuses on patients diagnosed with epilepsy, utilizing whole exome sequencing (WES) to identify potential genetic mutations. The study will also analyze the relationship between genotype and phenotype to improve personalized treatment approaches. Data will be gathered from both patients and their parents to enhance the understanding of hereditary factors in epilepsy.
Why it matters
Potential benefit: If successful, this study could lead to more accurate diagnoses and personalized treatment plans for patients with epilepsy.
How similar studies have gone: Other studies utilizing genetic sequencing for epilepsy have shown promise, indicating that this approach could be beneficial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Study population: patients with epilepsy. Patients who meet all of the following criteria will be included: * Patients both minors and adults diagnosed with epilepsy; * of both sexes; * followed at the pediatric and adult epilepsy and electroencephalography clinics of the U.O.C. Neurophysiopathology - IRCCS Ca' Granda Fondazione Ospedale Maggiore Policlinico; * Informed consent of the patient if an adult and capable of providing consent independently or of the parents or legal guardians in the case of a minor/individual not capable of providing consent independently. Inclusion criteria for exome candidate patients: * Availability of DNA samples from the patient and both natural parents; * Prediction of high positive genetic diagnosis Patients diagnosed with epilepsy will be recruited among those followed at the pediatric and adult epilepsy and electroencephalography clinics of the U.O.C. Neurophysiopathology - Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, after signing the consent. Exclusion Criteria: * Patients who possess at least one of the following criteria will be excluded: * Patients arriving for evaluation with the initial suspicion of epilepsy who during the diagnostic work-up were found to be suffering from a different pathology; * Patients who have refused consent to participate in the study.
Where it's running
-
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, Italy Recruiting
Study contacts
- Principal investigator: Robertino Dilena, MD — Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- Study coordinator: Federica Massacesi
- Email: federica.massacesi@policlinico.mi.it
- Phone: +390255032982
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
RAP-219 long-acting injectable safety and PK study in healthy adults
This early study tests RAP-219-LAI in healthy adults to see how it behaves in the body and whether it is safe and tolerable.
-
Why People with Epilepsy Get More Infections
This study tests whether anti-seizure medicines affect immune function and infection risk in people with epilepsy.
-
Long-Term Epilepsy Outcomes in Children After Perinatal Stroke
This study looks at how epilepsy progresses in kids who had a stroke before 28 days old to see how their seizures and syndromes evolve over time.
-
Hypothalamus structure and heart autonomic changes in drug-resistant epilepsy
This study tests whether structural changes in the hypothalamus relate to cardiac autonomic dysfunction in adults with drug-resistant epilepsy.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Advanced 7T fMRI for brain function in epilepsy and brain injuries
This study tests ultra-high-field brain scans at 7T to see if they can better map brain function in adults with epilepsy or brain lesions and in healthy volunteers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.